213 related articles for article (PubMed ID: 35264561)
1. Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43.
Garcia Morato J; Hans F; von Zweydorf F; Feederle R; Elsässer SJ; Skodras AA; Gloeckner CJ; Buratti E; Neumann M; Kahle PJ
Nat Commun; 2022 Mar; 13(1):1223. PubMed ID: 35264561
[TBL] [Abstract][Full Text] [Related]
2. An acetylation switch controls TDP-43 function and aggregation propensity.
Cohen TJ; Hwang AW; Restrepo CR; Yuan CX; Trojanowski JQ; Lee VM
Nat Commun; 2015 Jan; 6():5845. PubMed ID: 25556531
[TBL] [Abstract][Full Text] [Related]
3. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
Hans F; Eckert M; von Zweydorf F; Gloeckner CJ; Kahle PJ
J Biol Chem; 2018 Oct; 293(41):16083-16099. PubMed ID: 30120199
[TBL] [Abstract][Full Text] [Related]
6. Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.
Mompeán M; Romano V; Pantoja-Uceda D; Stuani C; Baralle FE; Buratti E; Laurents DV
J Biol Chem; 2017 Jul; 292(28):11992-12006. PubMed ID: 28566288
[TBL] [Abstract][Full Text] [Related]
7. Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43.
Keating SS; Bademosi AT; San Gil R; Walker AK
Cell Mol Life Sci; 2023 Mar; 80(4):95. PubMed ID: 36930291
[TBL] [Abstract][Full Text] [Related]
8. The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization.
Prasad A; Sivalingam V; Bharathi V; Girdhar A; Patel BK
Biochimie; 2018 Jul; 150():76-87. PubMed ID: 29751083
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 N-terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate.
Miura M; Sakaue F; Matsuno H; Morita K; Yoshida A; Hara RI; Nishimura R; Nishida Y; Yokogawa M; Osawa M; Yokota T
FEBS Lett; 2023 Jun; 597(12):1667-1676. PubMed ID: 37177801
[TBL] [Abstract][Full Text] [Related]
10. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
12. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
[TBL] [Abstract][Full Text] [Related]
13. A 43-kDa TDP-43 species is present in aggregates associated with frontotemporal lobar degeneration.
Bosque PJ; Boyer PJ; Mishra P
PLoS One; 2013; 8(5):e62301. PubMed ID: 23704877
[TBL] [Abstract][Full Text] [Related]
14. RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43.
Zacco E; Graña-Montes R; Martin SR; de Groot NS; Alfano C; Tartaglia GG; Pastore A
J Mol Biol; 2019 Apr; 431(8):1671-1688. PubMed ID: 30742796
[TBL] [Abstract][Full Text] [Related]
15. SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution.
Maraschi A; Gumina V; Dragotto J; Colombrita C; Mompeán M; Buratti E; Silani V; Feligioni M; Ratti A
Mol Neurobiol; 2021 Nov; 58(11):5682-5702. PubMed ID: 34390468
[TBL] [Abstract][Full Text] [Related]
16. Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation.
Gruijs da Silva LA; Simonetti F; Hutten S; Riemenschneider H; Sternburg EL; Pietrek LM; Gebel J; Dötsch V; Edbauer D; Hummer G; Stelzl LS; Dormann D
EMBO J; 2022 Apr; 41(8):e108443. PubMed ID: 35112738
[TBL] [Abstract][Full Text] [Related]
17. Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Riku Y; Seilhean D; Duyckaerts C; Boluda S; Iguchi Y; Ishigaki S; Iwasaki Y; Yoshida M; Sobue G; Katsuno M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917673
[TBL] [Abstract][Full Text] [Related]
18. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
19. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions.
Watanabe R; Higashi S; Nonaka T; Kawakami I; Oshima K; Niizato K; Akiyama H; Yoshida M; Hasegawa M; Arai T
Acta Neuropathol Commun; 2020 Oct; 8(1):176. PubMed ID: 33115537
[TBL] [Abstract][Full Text] [Related]
20. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
